Global Formulation Development Outsourcing Market 2022-2028
Description
Global Formulation Development Outsourcing Market 2022-2028
According to Gen Consulting Company, the global formulation development outsourcing market is set to achieve an incremental growth of USD 8 billion, acelerating at a CAGR of almost 7.1% during the forecast period 2022-2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global formulation development outsourcing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the formulation development outsourcing industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the service, dosage form, application, end user, and region. The global market for formulation development outsourcing can be segmented by service: formulation optimization, pre-formulation services. Formulation development outsourcing market is further segmented by dosage form: inhaled, injectable, oral, topical, others. Based on application, the formulation development outsourcing market is segmented into: cardiovascular, genetic disorders, infectious diseases, neurology, oncology, respiratory, others. On the basis of end user, the formulation development outsourcing market also can be divided into: government and academic institutes, pharmaceutical and biopharmaceutical companies. Formulation development outsourcing market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW).
By service:
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
According to Gen Consulting Company, the global formulation development outsourcing market is set to achieve an incremental growth of USD 8 billion, acelerating at a CAGR of almost 7.1% during the forecast period 2022-2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global formulation development outsourcing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the formulation development outsourcing industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the service, dosage form, application, end user, and region. The global market for formulation development outsourcing can be segmented by service: formulation optimization, pre-formulation services. Formulation development outsourcing market is further segmented by dosage form: inhaled, injectable, oral, topical, others. Based on application, the formulation development outsourcing market is segmented into: cardiovascular, genetic disorders, infectious diseases, neurology, oncology, respiratory, others. On the basis of end user, the formulation development outsourcing market also can be divided into: government and academic institutes, pharmaceutical and biopharmaceutical companies. Formulation development outsourcing market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW).
By service:
- formulation optimization
- pre-formulation services
- inhaled
- injectable
- oral
- topical
- others
- cardiovascular
- genetic disorders
- infectious diseases
- neurology
- oncology
- respiratory
- others
- government and academic institutes
- pharmaceutical and biopharmaceutical companies
- North America
- Asia Pacific
- Europe
- Rest of the World (ROW)
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global formulation development outsourcing market.
- To classify and forecast the global formulation development outsourcing market based on service, dosage form, application, end user, region.
- To identify drivers and challenges for the global formulation development outsourcing market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global formulation development outsourcing market.
- To identify and analyze the profile of leading players operating in the global formulation development outsourcing market.
- Gain a reliable outlook of the global formulation development outsourcing market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
Table of Contents
74 Pages
- PART 1. INTRODUCTION
- Report description
- Objectives of the study
- Market segment
- Years considered for the report
- Currency
- Key target audience
- PART 2. METHODOLOGY
- PART 3. EXECUTIVE SUMMARY
- PART 4. MARKET OVERVIEW
- Introduction
- Drivers
- Restraints
- Impact of COVID-19 pandemic
- PART 5. MARKET BREAKDOWN BY SERVICE
- Formulation optimization
- Pre-formulation services
- PART 6. MARKET BREAKDOWN BY DOSAGE FORM
- Inhaled
- Injectable
- Oral
- Topical
- Others
- PART 7. MARKET BREAKDOWN BY APPLICATION
- Cardiovascular
- Genetic disorders
- Infectious diseases
- Neurology
- Oncology
- Respiratory
- Others
- PART 8. MARKET BREAKDOWN BY END USER
- Government and academic institutes
- Pharmaceutical and biopharmaceutical companies
- PART 9. MARKET BREAKDOWN BY REGION
- North America
- Asia Pacific
- Europe
- Rest of the World (ROW)
- PART 10. KEY COMPANIES
- Aizant Drug Research Solutions Private Limited
- Biocon Limited (Syngene International Limited)
- Catalent Inc.
- Charles River Laboratories International Inc.
- Emergent BioSolutions Inc.
- Intertek Group plc
- IRISYS LLC
- Laboratory Corporation of America Holdings (LabCorp)
- Lonza Group AG
- PCI Pharma Services, Inc. (PCI)
- Piramal Enterprises Ltd
- Quotient Sciences Limited
- Thermo Fisher Scientific Inc. (Patheon N.V.)
- *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
- DISCLAIMER
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
